Acute renal failure from
ischemia significantly contributes to cardiovascular morbidity and mortality. Extracellular
adenosine has been implicated as an anti-inflammatory metabolite particularly during conditions of limited
oxygen availability (e.g.,
ischemia). Because
ecto-5'-nucleotidase (CD73) is rate limiting for extracellular
adenosine generation, this study examined the contribution of CD73-dependent
adenosine production to ischemic preconditioning (IP) of the kidneys. After the initial observation that murine CD73 transcript,
protein, and function are induced by renal IP, its role in IP-mediated kidney protection was studied. In fact, increases in renal
adenosine concentration with IP are attenuated in cd73(-/-) mice. Moreover, pharmacologic inhibition of CD73 or its targeted gene deletion abolished renal protection by IP as measured by clearance studies, plasma
electrolytes, and renal tubular destruction, and reconstitution of cd73(-/-) mice with soluble
5'-nucleotidase resulted in complete restoration of renal protection by IP. Finally, renal injury after
ischemia was attenuated by intraperitoneal treatment of wild-type mice with soluble
5'-nucleotidase to a similar degree as by IP. Taken together, these data reveal what is believed to be a previously unrecognized role of CD73 in renal protection from
ischemia and suggest treatment with soluble
5'-nucleotidase as a novel therapeutic approach in the treatment of renal diseases that are precipitated by limited
oxygen availability.